Literature DB >> 18754611

Aminoacyl-anthraquinone conjugates as telomerase inhibitors: synthesis, biophysical and biological evaluation.

Giuseppe Zagotto1, Claudia Sissi, Lorena Lucatello, Claudia Pivetta, Sergio A Cadamuro, Keith R Fox, Stephen Neidle, Manlio Palumbo.   

Abstract

The telomerase-telomere complex is a prospective anticancer target. To inhibit enzyme activity by induction of G-quadruplex in human telomeres, we have synthesized a small library of 2,6- and 2,7-amino-acyl/ peptidyl anthraquinones with diverse connecting linkers, charge, lipophilicity and bulk. The test compounds modulated G-quadruplex stability to different extents and showed clear preference for quadruplex over duplex DNA. Telomerase inhibition correlated with G-quadruplex stabilization. A SAR analysis showed that type of linkage between the linker and the anthraquinone, together with the position of the side chains and the nature of the amino acid components play a major role both in stabilizing G-quadruplex and producing telomerase inhibition. Short-term cytotoxic activity was poor. However, after prolonged exposure to effective G-quadruplex binders, cells became senescent. These results are of help in the rational design of more efficient G-quadruplex stabilizers, possibly endowed with cancer cell-selective antiproliferative effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18754611     DOI: 10.1021/jm800160v

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Structure of a stacked anthraquinone-DNA complex.

Authors:  Daniela De Luchi; Isabel Usón; Glenford Wright; Catherine Gouyette; Juan A Subirana
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-08-21

2.  DNA adducts of antitumor cisplatin preclude telomeric sequences from forming G quadruplexes.

Authors:  Pavla Heringova; Jana Kasparkova; Viktor Brabec
Journal:  J Biol Inorg Chem       Date:  2009-04-24       Impact factor: 3.358

3.  Anthraquinone Derivatives as Potent Inhibitors of c-Met Kinase and the Extracellular Signaling Pathway.

Authors:  Zhongjie Liang; Jing Ai; Xiao Ding; Xia Peng; Dengyou Zhang; Ruihan Zhang; Ying Wang; Fang Liu; Mingyue Zheng; Hualiang Jiang; Hong Liu; Meiyu Geng; Cheng Luo
Journal:  ACS Med Chem Lett       Date:  2013-02-25       Impact factor: 4.345

4.  Multiple in Vitro Inhibition of HIV-1 Proteins by 2,6-Dipeptidyl-anthraquinone Conjugates Targeting the PBS RNA.

Authors:  Elia Gamba; Alice Sosic; Irene Saccone; Elisa Magli; Francesco Frecentese; Barbara Gatto
Journal:  ACS Med Chem Lett       Date:  2020-03-23       Impact factor: 4.345

5.  Thiol-functionalized anthraquinones: mass spectrometry and electrochemical studies.

Authors:  Paweł Niedziałkowski; Tadeusz Ossowski; Radosław Majewski; Zdzisława Nowakowska; Grzegorz Schroeder
Journal:  Monatsh Chem       Date:  2011-09-09       Impact factor: 1.451

6.  Inhibition of the thioesterase activity of human fatty acid synthase by 1,4- and 9,10-diones.

Authors:  Herman Odens; Todd Lowther; Steven Kridel; Laura Watts; Lauren Filipponi; Jeffrey Schmitt
Journal:  Chem Pharm Bull (Tokyo)       Date:  2014       Impact factor: 1.645

7.  Target Based Designing of Anthracenone Derivatives as Tubulin Polymerization Inhibiting Agents: 3D QSAR and Docking Approach.

Authors:  Abdul Samad; Moawiah M Naffaa; Mohammed Afroz Bakht; Manav Malhotra; Majid A Ganaie
Journal:  Int J Med Chem       Date:  2014-04-17

8.  Mitoxantrone and Analogues Bind and Stabilize i-Motif Forming DNA Sequences.

Authors:  Elisé P Wright; Henry A Day; Ali M Ibrahim; Jeethendra Kumar; Leo J E Boswell; Camille Huguin; Clare E M Stevenson; Klaus Pors; Zoë A E Waller
Journal:  Sci Rep       Date:  2016-12-22       Impact factor: 4.379

9.  Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation.

Authors:  Lien-Cheng Chang; Tsung-Chih Chen; Shiag-Jiun Chen; Chun-Liang Chen; Chia-Chung Lee; Shih-Hsiung Wu; Yun Yen; Hsu-Shan Huang; Jing-Jer Lin
Journal:  Oncotarget       Date:  2016-10-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.